Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 Days On/3 Days Off Maintenance Strategy in HIV-1 (ANRS 162-4D)
NCT02157311Phase 3Completed
- Sponsor
- ANRS
- Start
- Jul 2014
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Primary endpoint: Capacity to maintain a therapeutic success at 48 weeks. Started Jul 2014; status: completed.
02
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02157311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157311.